Ignite Creation Date:
2024-05-06 @ 5:43 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05408780
Status:
COMPLETED
Last Update Posted:
2023-10-17
First Post:
2022-05-31
Brief Title:
A Phase 1 Two-part Randomized Study to Evaluate the Pharmacokinetics Safety and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects
Sponsor:
Cerecin
Organization:
Cerecin
Study Overview
Official Title:
A Phase 1 Two-part Randomized Study to Evaluate the Pharmacokinetics Safety and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo to Include Single-dose and Food Effect Part A and Titration Tolerability Part B in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the PK safety and tolerability of a new liquid formulation of tricaprilin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None